Expression of HNF4α variants in pancreatic islets and Ins-1 β cells

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue 7, 2008, Pages 533-543

  Huang, Jianmin ^a   Karakucuk, Vildan ^a   Levitsky, Lynne L ^a   Rhoads, David B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alternative splicing; Hormone nuclear receptor; Transcriptional activity

Indexed keywords

CELL NUCLEUS RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA3; HEPATOCYTE NUCLEAR FACTOR 4ALPHA6; HEPATOCYTE NUCLEAR FACTOR 4ALPHA9; MESSENGER RNA; UNCLASSIFIED DRUG; HEPATOCYTE NUCLEAR FACTOR 4;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXON; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES CONSERVATION; ANIMAL; BIOSYNTHESIS; CELL STRAIN COS1; CERCOPITHECUS; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; PANCREAS ISLET; RAT; SEQUENCE ALIGNMENT;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; COS CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT;

EID: 58149151122     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.870     Document Type: Article

References (50)

1. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889-895.
2. Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE Jr, Crabtree GR. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 1992; 355: 457-461.
3. Yamagata K, Furuta H, Oda N, et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384: 458-460.
4. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971-980.
5. Gupta RK, Kaestner KH. HNF-4α: from MODY to late-onset type 2 diabetes. Trends Mol Med 2004; 10: 521-524.
6. Mohlke KL, Boehnke M. The role of HNF4A variants in the risk of type 2 diabetes. Curr Diab Rep 2005; 5: 149-156.
7. Shaat N, Karlsson E, Lernmark A, et al. Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 2006; 49: 1545-1551.
8. Chen WS, Manova K, Weinstein DC, et al. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev 1994; 8: 2466-2477.
9. Miura A, Yamagata K, Kakei M, et al. Hepatocyte nuclear factor-4α is essential for glucose-stimulated insulin secretion by pancreatic β-cells. J Biol Chem 2006; 281: 5246-5257.
10. Furuta H, Iwasaki N, Oda N, et al. Organization and partial sequence of the hepatocyte nuclear factor-4α/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 1997; 46: 1652-1657.
11. Nakhei H, Lingott A, Lemm I, Ryffel GU. An alternative splice variant of the tissue specific transcription factor HNF4α predominates in undifferentiated murine cell types. Nucleic Acids Res 1998; 26: 497-504.
12. Torres-Padilla ME, Fougere-Deschatrette C, Weiss MC. Expression of HNF4α isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3′ end splicing. Mech Dev 2001; 109: 183-193.
13. Boj SF, Parrizas M, Maestro MA, Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci U S A 2001; 98: 14481-14486.
14. Thomas H, Jaschkowitz K, Bulman M, et al. A distant upstream promoter of the HNF-4α gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum Mol Genet 2001; 10: 2089-2097.
15. Hansen SK, Parrizas M, Jensen ML, et al. Genetic evidence that HNF-1α-dependent transcriptional control of HNF-4α is essential for human pancreatic β cell function. J Clin Invest 2002; 110: 827-833.
16. Hadzopoulou-Cladaras M, Kistanova E, Evagelopoulou C, Zeng S, Cladaras C, Ladias JA. Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J Biol Chem 1997; 272: 539-550.
17. Sladek FM, Ruse MD Jr, Nepomuceno L, Huang SM, Stallcup MR. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4α1. Mol Cell Biol 1999; 19: 6509-6522.
18. Eeckhoute J, Moerman E, Bouckenooghe T, et al. Hepatocyte nuclear factor 4α isoforms originated from the P1 promoter are expressed in human pancreatic β-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms. Endocrinology 2003; 144: 1686-1694.
19. Ihara A, Yamagata K, Nammo T, et al. Functional characterization of the HNF4α isoform (HNF4α8) expressed in pancreatic β-cells. Biochem Biophys Res Commun 2005; 329: 984-990.
20. Drewes T, Senkel S, Holewa B, Ryffel GU. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol 1996; 16: 925-931.
21. Torres-Padilla ME, Sladek FM, Weiss MC. Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4α mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes. J Biol Chem 2002; 277: 44677-44687.
22. Briancon N, Weiss MC. In vivo role of the HNF4α AF-1 activation domain revealed by exon swapping. EMBO J 2006; 25: 1253-1262.
23. Hata S, Tsukamoto T, Osumi T. A novel isoform of rat hepatocyte nuclear factor 4 (HNF-4). Biochim Biophys Acta 1992; 1131: 211-213.
24. Chartier FL, Bossu JP, Laudet V, Fruchart JC , Laine B. Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver. Gene 1994; 147: 269-272.
25. Taraviras S, Monaghan AP, Schutz G, Kelsey G. Characterization of the mouse HNF-4 gene and its expression during mouse embryogenesis. Mech Dev 1994; 48: 67-79.
26. Hata S, Inoue T, Kosuga K, Nakashima T, Tsukamoto T, Osumi T. Identification of two splice isoforms of mRNA for mouse hepatocyte nuclear factor 4 (HNF-4). Biochim Biophys Acta 1995; 1260: 55-61.
27. Kritis AA, Argyrokastritis A, Moschonas NK, et al. Isolation and characterization of a third isoform of human hepatocyte nuclear factor 4. Gene 1996; 173: 275-280.
28. Wang B, Cai SR, Gao C, Sladek FM, Ponder KP. Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4α in rat liver. Hepatology 2001; 34: 979-989.
29. Tanaka T, Jiang S, Hotta H, et al. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4α in the pathogenesis of human cancer. J Pathol 2006; 208: 662-672.
30. Ahn YB, Xu G, Marselli L, et al. Changes in gene expression in beta cells after islet isolation and transplantation using laser-capture microdissection. Diabetologia 2007; 50: 334-342.
31. Shim JH, Kim SE, Woo DH, et al. Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia 2007; 50: 1228-1238.
32. Yang F, Agulian T, Sudati JE, Rhoads DB, Levitsky LL. Developmental regulation of galactokinase in suckling mouse liver by the Egr-1 transcription factor. Pediatr Res 2004; 55: 822-829.
33. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 1992; 130: 167-178.
34. Wang L, Coffinier C, Thomas MK, et al. Selective deletion of the Hnf1β (MODY5) gene in β cells leads to altered gene expression and defective insulin release. Endocrinology 2004; 145: 3941-3949.
35. Gattoni-Celli S, Kirsch K, Kalled S, Isselbacher KJ. Expression of type C-related endogenous retroviral sequences in human colon tumors and colon cancer cell lines. Proc Natl Acad Sci U S A 1986; 83: 6127-6131.
36. Jiang G, Nepomuceno L, Yang Q, Sladek FM. Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4. Arch Biochem Biophys 1997; 340: 1-9.
37. Lu M, Seufert J, Habener JF. Pancreatic β-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein β. Inhibitory interactions with basic helix-loop-helix transcription factor E47. J Biol Chem 1997; 272: 28349-28359.
38. Jung D, Kullak-Ublick GA. Hepatocyte nuclear factor 1α: a key mediator of the effect of bile acids on gene expression. Hepatology 2003; 37: 622-631.
39. Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004; 47: 240-248.
40. Miura N, Tanaka K. Analysis of the rat hepatocyte nuclear factor (HNF) 1 gene promoter: synergistic activation by HNF4 and HNF1 proteins. Nucleic Acids Res 1993; 21: 3731-3736.
41. Piaggio G, Tomei L, Toniatti C, De Francesco R, Gerstner J, Cortese R. LFB1/HNF1 acts as a repressor of its own transcription. Nucleic Acids Res 1994; 22: 4284-4290.
42. Gragnoli C, Lindner T, Cockburn BN, et al. Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4α binding site in the promoter of the hepatocyte nuclear factor-1α gene. Diabetes 1997; 46: 1648-1651.
43. Lucas Sd S, Lopez-Alcorocho JM, Bartolome J, Carreno V. Nitric oxide and TGF-β1 inhibit HNF-4α function in HEPG2 cells. Biochem Biophys Res Commun 2004; 321: 688-694.
44. Reed R. Initial splice-site recognition and pairing during pre-mRNA splicing. Curr Opin Genet Dev 1996; 6: 215-220.
45. Ferrer J. A genetic switch in pancreatic β-cells: implications for differentiation and haploinsufficiency. Diabetes 2002; 51: 2355-2362.
46. Servitja JM, Ferrer J. Transcriptional networks controlling pancreatic development and β cell function. Diabetologia 2004; 47: 597-613.
47. Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1α (HNF1A) and 4α (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 2006; 27 : 854-869.
48. Cicchini C, Ansuini H, Amicone L, et al. Searching for DNA-protein interactions by lambda phage display. J Mol Biol 2002; 322: 697-706.
49. Hani EH, Suaud L, Boutin P, et al. A missense mutation in hepatocyte nuclear factor-4α, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus. J Clin Invest 1998; 101: 521-526.
50. Aguilera E, Casamitjana R, Ercilla G, Oriola J, Gomis R, Conget I. Adult-onset atypical (type 1) diabetes: additional insights and differences with type 1A diabetes in a European Mediterranean population. Diabetes Care 2004; 27: 1108-1114.